Morse Asset Management’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-435
Closed -$271K 176
2021
Q3
$271K Sell
435
-10
-2% -$6.72K 0.06% 144
2021
Q2
$281K Buy
445
+15
+3% +$8.28K 0.07% 144
2021
Q1
$210K Sell
430
-530
-55% -$266K 0.05% 147
2020
Q4
$480K Sell
960
-123
-11% -$55K 0.13% 105
2020
Q3
$426K Buy
+1,083
New +$400K 0.14% 98
2018
Q4
Sell
-18,042
Closed -$4.5M 125
2018
Q3
$4.5M Buy
18,042
+355
+2% +$86.2K 1.19% 25
2018
Q2
$3.85M Buy
17,687
+1,265
+8% +$261K 1.06% 29
2018
Q1
$3.14M Buy
+16,422
New +$3.03M 0.87% 36

Other funds holding IDXX

Morse Asset Management's IDXX Position: Q4 2021 in Review

Morse Asset Management sold out of Idexx Laboratories (IDXX) in Q4 2021, closing a stake of 435 shares — an estimated $271K sold.

Morse Asset Management first reported a position in IDXX in Q1 2018 and held it in 8 quarters. The position peaked at $4.5M in Q3 2018. 1,107 funds tracked by Wall St. Rank hold IDXX as of Q4 2021.

  • Morse Asset Management reported no remaining Idexx Laboratories position as of Q4 2021 after selling out during the quarter.
  • Morse Asset Management sold 435 Idexx Laboratories shares in Q4 2021, an estimated $271K.
  • Morse Asset Management first reported a position in Idexx Laboratories in Q1 2018 and held it in 8 quarters.
  • Morse Asset Management's Idexx Laboratories position peaked at $4.5M in Q3 2018.
  • 1,107 funds tracked by Wall St. Rank held Idexx Laboratories as of Q4 2021.

Based on Morse Asset Management's 13F filing for Q4 2021, filed 14 Feb 2022.